Pharmaceutical Sciences: IAJPS 2018, 05 (05), 3705-3709 Iqra Shoukat
Pharmaceutical Sciences: IAJPS 2018, 05 (05), 3705-3709 Iqra Shoukat
Pharmaceutical Sciences: IAJPS 2018, 05 (05), 3705-3709 Iqra Shoukat
Please cite this article in press Iqra Shoukat et al., An Experimental and Comparative Research On the Core
Stabilization Effects in the Absence and Presence of Conventional Physical Therapies to Manage Non-Specified
Pain in the Lower Back Area: Mayo Hospital, Lahore, Indo Am. J. P. Sci, 2018; 05(05).
Table – I: Paired T – test for group “A” (number = 20) given core stabilization exercises and conventional
therapy.
Variables Mean Std. Deviation T P – value
VAS (pre)
Pair 1 3.99444 1.57871 10.735 0
VAS (post)
MODQ (pre)
Pair 2 19.77778 18.11257 4.633 0
MODQ (post)
4.633
T
10.735
18.11257
Std. Deviation
1.57871
19.77778
Mean
3.99444
0 5 10 15 20 25
Table – II: Paired T – Test for group “B” (number = 20) given core stabilization exercises alone
Std.
Variables Mean t p-value
Deviation
VAS (pre)
Pair 1 3.65 1.3518 11.456 0
VAS (post)
MoDQ (pre)
Pair 2 24.88889 14.54765 7.259 0
MoDQ (post)
0
p-value
0
7.259
t
11.456
14.54765
Std. Deviation
1.3518
24.88889
Mean
3.65
0 5 10 15 20 25 30
*p-value (<0.05)
Improvement was observed in both A and B groups current literature part 2.American Journal of
for functional activity and pain; whereas, A group Physical Medicine and Rehabilitation, 2006; 86
was treated with the core stabilization exercises (1): 72-80.
assisted with the conventional treatment which 13. Heck JF, Sparano, JM.A classification system for
reflected a bit of improvement in the function and the assessment of lumbar pain in athletes.
pain in B group. For the attainment of better Journal of Athletic Training, 2000; 35 (2): 204-
outcomes any of the mentioned intervention can be 211.
used in order to produce effective management. 14. Ferreira PH, Ferreira ML. Specific stabilization
exercise for spinal and pelvic pain. Australian J
REFERENCES: of Physiotherapy, 2006; (52): 79-88.
1. Krismer M, Van Tulder M. Strategies for
prevention and management of musculoskeletal
conditions. Low back pain (non-specific). Best
Practice and Research. Clinical Rheumatology,
2007; (21) 1: 77-91.
2. Van Tulder, MW Waddell, G. Evidence – based
medicine for Non-Specific Low back pain. Best
Practice and Research. Clinical Rheumatology,
2005; (19): 1521-694.
3. Patricia A Downie. Cash’s textbook of orthopedics
and rheumatology for physiotherapists, 1st
Indian ed. Vol.18. New York: Mosby; 1993.
4. Neal C. The assessment of knowledge and
application of proper body mechanics in the
workspace. Orthopedics Nurse, 1998; 16 (66):
34-36.
5. Bogduk M. Management of chronic Low Back
Pain. Medical journal of Australia, 2003; 180
(2): 79-83.
6. Van Tulder MW, Scholten RJPM, Koes BW, Deyo
RA. Non-steroidal anti-inflammatory drugs
(NSAIDs) for nonspecific low back pain
(Cochrane Review). In: The Cochrane Library,
2000; (4).
7. Van Tulder MW, Touray T, Furlan AD, SolwayS,
Bouter LM. Muscle relaxants for nonspecific
low backpain (Cochrane Review). In: The
Cochrane Library.2004; (1).
8. Stephane Poitras, Luci Brosseau. Evidence –
informed management of chronic low back pain
with Transcutaneous Electrical Nerve
stimulation, Interferential current, Electrical
muscle stimulation, Ultrasound and
Thermotherapy. The Spine journal, 2008; 8: 226-
233.
9. Kibler, B.W., Press, J., and Sciascia, A. The role of
core stability in athletic function Sports
Medicine, 2006; 36 (3): 189-198.
10. Andersson GBJ. Epidemiology of low back pain.
Acta Orthop Scand. 2000; 69 (281): 28.
11. Bigos S, Bowyer. Acute Low back pain problems
in adults. Clinical Practice Guidelines, No 14.
ServicesPublic Health Service Agency for Health
Care Policy and Research 1994.
12. Barr K, Griggs M, Cad by, T. Lumbar
Stabilization: A review of core concepts and